Cargando…

Drug-induced esophagitis and helpful management for healthcare providers

In recent decades, the number of cases developing drug-induced esophagitis (DIE) has reportedly been growing, which indicates the significance of detecting medicines capable of causing this adverse reaction. This study aims to provide an updated review on recent case reports of DIE, to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdi, Saeed, Masbough, Farnoosh, Nazari, Maryam, Abbasinazari, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589134/
https://www.ncbi.nlm.nih.gov/pubmed/36311965
http://dx.doi.org/10.22037/ghfbb.v15i3.2591
_version_ 1784814233830031360
author Abdi, Saeed
Masbough, Farnoosh
Nazari, Maryam
Abbasinazari, Mohammad
author_facet Abdi, Saeed
Masbough, Farnoosh
Nazari, Maryam
Abbasinazari, Mohammad
author_sort Abdi, Saeed
collection PubMed
description In recent decades, the number of cases developing drug-induced esophagitis (DIE) has reportedly been growing, which indicates the significance of detecting medicines capable of causing this adverse reaction. This study aims to provide an updated review on recent case reports of DIE, to evaluate the possible mechanism of this side effect, and to provide helpful management. Data was gathered through searches of three databases, namely PubMed, Medline, and Cochrane. Seven drug categories were evaluated: antibiotics, bisphosphonates, cardiovascular medicines, chemotherapeutic agents, non-steroidal anti-inflammatory drugs (NSAIDs), other medications, and supplements. According to the findings, retrosternal pain, heartburn, odynophagia, and dysphagia are typical symptoms of DIE, and in most cases, DIE is a self-limiting side effect which can be resolved by removing the causative agent and providing supportive therapy.
format Online
Article
Text
id pubmed-9589134
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-95891342022-10-28 Drug-induced esophagitis and helpful management for healthcare providers Abdi, Saeed Masbough, Farnoosh Nazari, Maryam Abbasinazari, Mohammad Gastroenterol Hepatol Bed Bench Review Article In recent decades, the number of cases developing drug-induced esophagitis (DIE) has reportedly been growing, which indicates the significance of detecting medicines capable of causing this adverse reaction. This study aims to provide an updated review on recent case reports of DIE, to evaluate the possible mechanism of this side effect, and to provide helpful management. Data was gathered through searches of three databases, namely PubMed, Medline, and Cochrane. Seven drug categories were evaluated: antibiotics, bisphosphonates, cardiovascular medicines, chemotherapeutic agents, non-steroidal anti-inflammatory drugs (NSAIDs), other medications, and supplements. According to the findings, retrosternal pain, heartburn, odynophagia, and dysphagia are typical symptoms of DIE, and in most cases, DIE is a self-limiting side effect which can be resolved by removing the causative agent and providing supportive therapy. Shaheed Beheshti University of Medical Sciences 2022 /pmc/articles/PMC9589134/ /pubmed/36311965 http://dx.doi.org/10.22037/ghfbb.v15i3.2591 Text en ©2022 RIGLD, Research Institute for Gastroenterology and Liver Diseases https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) which permits others to copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Review Article
Abdi, Saeed
Masbough, Farnoosh
Nazari, Maryam
Abbasinazari, Mohammad
Drug-induced esophagitis and helpful management for healthcare providers
title Drug-induced esophagitis and helpful management for healthcare providers
title_full Drug-induced esophagitis and helpful management for healthcare providers
title_fullStr Drug-induced esophagitis and helpful management for healthcare providers
title_full_unstemmed Drug-induced esophagitis and helpful management for healthcare providers
title_short Drug-induced esophagitis and helpful management for healthcare providers
title_sort drug-induced esophagitis and helpful management for healthcare providers
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589134/
https://www.ncbi.nlm.nih.gov/pubmed/36311965
http://dx.doi.org/10.22037/ghfbb.v15i3.2591
work_keys_str_mv AT abdisaeed druginducedesophagitisandhelpfulmanagementforhealthcareproviders
AT masboughfarnoosh druginducedesophagitisandhelpfulmanagementforhealthcareproviders
AT nazarimaryam druginducedesophagitisandhelpfulmanagementforhealthcareproviders
AT abbasinazarimohammad druginducedesophagitisandhelpfulmanagementforhealthcareproviders